AHCL vs SAIPARENT: Stock Comparison

Anlon Healthcare Limited vs Sai Parenterals Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Sai Parenterals Ltd is the larger company by market capitalisation. Anlon Healthcare Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anlon Healthcare Limited and Sai Parenterals Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AHCL is more favourable on 8 of 11 scored metrics and SAIPARENT on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SAIPARENT is the larger company
₹2,365 Cr vs ₹797 Cr
P/E Ratio
AHCL has a lower P/E
27.78x vs 167.17x
P/B Ratio
AHCL has a lower P/B
3.46x vs 4.86x
EPS
SAIPARENT has higher earnings per share
₹3.23 vs ₹0.61
Revenue Growth (TTM YoY)
AHCL has faster revenue growth
4% vs 0%
EPS Growth (TTM YoY)
SAIPARENT has faster EPS growth
0% vs -54.8%
ROE
AHCL has a higher ROE
18.4% vs 4.88%
ROCE
AHCL has a higher ROCE
20.8% vs 5.97%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAHCLSAIPARENT
SectorHealthcare
IndustryPharmaceuticals

Price

MetricAHCLSAIPARENT
Live Price₹15.01₹535.6
Day Change-0.46%-0.76%
Volume28.27 L63,939
52-Week High₹161₹706
52-Week Low₹12.91₹400
Distance from 52W High-90.68%-24.14%

Valuation

MetricAHCLSAIPARENT
Market Cap₹797 Cr₹2,365 Cr
P/E Ratio27.78x167.17x
P/B Ratio3.46x4.86x
EPS₹0.61₹3.23
Book Value₹5.11
Dividend Yield0%0%

Growth

MetricAHCLSAIPARENT
Revenue Growth (TTM YoY)4%0%
EPS Growth (TTM YoY)-54.8%0%
Qtr Sales Growth4.01%
Qtr Profit Growth-36.9%

Profitability & Leverage

MetricAHCLSAIPARENT
ROE18.4%4.88%
ROCE20.8%5.97%
Net Margin22.18%3.74%
Operating Margin27.6%10.2%
Debt to Equity0.19x0.68x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricAHCLSAIPARENT
Promoter Holding52.68%51.16%
FII Holding0.32% 0.09 pp5.73%
DII Holding4.6% 0.11 pp12.86%
Public Holding42.4% 0.2 pp30.26%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anlon Healthcare Limited and Sai Parenterals Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.